Requisite Capital Management, LLC Bristol Myers Squibb CO Transaction History

Requisite Capital Management, LLC

  • $456 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020
SELL
$46.4 - $67.43 $357,280 - $519,211
-7,700 Closed
0 $0
Q4 2019

Feb 13, 2020
SELL
$49.21 - $64.19 $541,310 - $706,090
-11,000 Reduced 58.82%
7,700 $494,000
Q2 2019

Aug 05, 2019
BUY
$44.62 - $49.34 $120,474 - $133,218
2,700 Added 16.88%
18,700 $848,000
Q1 2019

May 15, 2019
BUY
$45.12 - $53.8 $721,920 - $860,800
16,000 New
16,000 $763,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Requisite Capital Management, LLC Portfolio

Follow Requisite Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Requisite Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Requisite Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email